Top

Published in:

01-06-2018 | Original Article

Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional study

Authors: Judit Tirado-Muñoz, Gail Gilchrist, Gabriele Fischer, Avril Taylor, Jacek Moskalewicz, Cinzia Giammarchi, Birgit Köchl, Alison Munro, Katarzyna Dąbrowska, April Shaw, Lucia Di Furia, Isabella Leeb, Caroline Hopf, Marta Torrens

Published in: Archives of Women's Mental Health | Issue 3/2018

Abstract

Women who inject drugs (WWID) are an especially vulnerable group of drug users. This study determined the prevalence of psychiatric comorbidity and intimate partrner violence (IPV), and factors associated with psychiatric comorbidity among WWID recruited from drug treatment services (67%) and harm reduction services in five European regions in Austria, Catalonia, Italy, Poland, and Scotland. Psychiatric comorbidity was assessed among 226 WWID using the Dual Diagnosis Screening Instrument. IPV was assessed using the Composite Abuse Scale and injecting and sexual risk behaviors were assessed using a battery of questionnaires adapted and developed for the study. Eighty-seven percent met criteria for at least one lifetime psychiatric disorder. The most common disorders were depression (76%), panic (54%), and post-traumatic stress (52%). WWID recruited in drug treatment services were almost three times as likely (OR 2.90 95% CI 1.30–6.43; p = 0.007) to meet criteria for a lifetime psychiatric disorder than those recruited from harm reduction services, specifically dysthymia (OR 5.32 95% CI 2.27–12.48; p = 0.000) and post-traumatic stress disorder (OR 1.83 95% CI 1.02–3.27; p = 0.040). WWID who reported sharing needles and syringes were almost three times as likely to meet criteria for lifetime psychiatric comorbidity than those who did not (OR 2.65 95% CI 1.07–6.56). Compared to WWID who had not experienced IPV, victims (70%) were almost two times more likely to meet criteria for post-traumatic stress disorder (OR 1.95 95% CI 1.10–3.48). Psychiatric comorbidity and IPV among WWID are common. Drug treatment and harm reduction services should address psychiatric comorbidity and IPV to improve treatment outcomes.

Anagnostopoulos A, Ledergerber B, Jaccard R, Shaw SA, Stoeckle M, Bernasconi E, Barth J, Calmy A, Berney A, Jenewein J, Weber R, Swiss HIV Cohort Study (2015) Frequency of and risk factors for depression among participants in the Swiss HIV Cohort Study (SHCS). PLoS One 10(10):e0140943. https://doi.org/10.1371/journal.pone.0140943 CrossRefPubMedPubMedCentral

Blasco-Ros C, Sánchez-Lorente S, Martinez M (2010) Recovery from depressive symptoms, state anxiety and post-traumatic stress disorder in women exposed to physical and psychological, but not to psychological intimate partner violence alone: a longitudinal study. BMC Psychiatry 10:98

Brook DW, Brook JS, Richter L, Masci JR, Roberto J (2000) Needle sharing: a longitudinal study of female injection drug users. Am J Drug Alcohol Abuse 26(2):263–281. https://doi.org/10.1081/ADA-100100604 CrossRefPubMed

Buckingham E, Schrage E, Cournos F (2013) Why the treatment of mental disorders is an important component of HIV prevention among people who inject drugs. Adv Prev Med 2013:690386CrossRefPubMedPubMedCentral

Cox J, De P, Morissette C, Tremblay C, Stephenson R, Allard R, Graves L, Roy E (2008) Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. Soc Sci Med 66(2):211–220. https://doi.org/10.1016/j.socscimed.2007.08.022 CrossRefPubMed

Crepaz N, Marks G (2001) Are negative affective states associated with HIV sexual risk behaviors? A meta-analytic review. Health Psychol 20(4):291–299. https://doi.org/10.1037/0278-6133.20.4.291 CrossRefPubMed

Daigre C, Rodriguez-Cintas L, Tarifa N, Rodriguez-Martos L, Grau-López L, Berenguer M, Casas M, Roncero C (2015) History of sexual, emotional or physical abuse and psychiatric comorbidity in substance-dependent patients. Psychiatry Res 229(3):743–749. https://doi.org/10.1016/j.psychres.2015.08.008 CrossRefPubMed

de Dios MA, Anderson BJ, Caviness CM, Stein M (2014) Intimate partner violence among individuals in methadone maintenance treatment. Subst Abus 35(2):190–193. https://doi.org/10.1080/08897077.2013.835764 CrossRefPubMedPubMedCentral

Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Hagan H (2012) Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Dependenc 24:95–107CrossRef

Devries KM, Mak JY, Bacchus LJ, Child JC, Falder G, Petzold M, Astbury J, Watts CH (2013) Intimate partner violence and incident depressive symptoms and suicide attempts: a systematic review of longitudinal studies. PLoS Med 10(5):e1001439. https://doi.org/10.1371/journal.pmed.1001439 CrossRefPubMedPubMedCentral

Devries KM, Child JC, Bacchus LJ, Mak J, Falder G, Graham K, Watts C, Heise L (2014) Intimate partner violence victimization and alcohol consumption in women: a systematic review and meta-analysis. Addiction 109(3):379–391. https://doi.org/10.1111/add.12393 CrossRefPubMed

Disney E, Kidorf M, Kolodner K, King V, Peirce J, Beilenson P, Brooner RK (2006) Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants. J Nerv Ment Dis 194(8):577–583. https://doi.org/10.1097/01.nmd.0000230396.17230.28 CrossRefPubMed

El-Bassel N, Strathdee SA (2015) Women who use or inject drugs: an action agenda for women-specific, multilevel, and combination HIV prevention and research. J Acquir Immune Defic Syndr 69(Suppl 2):S182–S190. https://doi.org/10.1097/QAI.0000000000000628 CrossRefPubMedPubMedCentral

El-Bassel N, Gilbert L, Schilling R, Wada T (2000) Drug abuse and partner violence among women in methadone treatment. J Fam Violence 15(3):209–228. https://doi.org/10.1023/A:1007532917759 CrossRef

El-Bassel N, Gilbert L, Wu E, Go H, Hill J (2005) HIV and intimate partner violence among methadone-maintained women in New York City. Soc Sci Med 61(1):171–183. https://doi.org/10.1016/j.socscimed.2004.11.035 CrossRefPubMed

El-Bassel N, Gilbert L, Witte S, Wu E, Chang M (2011) Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics—challenges and implications for prevention and treatment. Subst Use Misuse 46(2–3):295–306. https://doi.org/10.3109/10826084.2011.523296 CrossRefPubMed

El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA (2014) People who inject drugs in intimate relationships: it takes two to combat HIV. Curr HIV/AIDS Rep 11(1):45–51. https://doi.org/10.1007/s11904-013-0192-6 CrossRefPubMedPubMedCentral

Gilbert L, El-Bassel N, Rajah V, Foleno A, Fontdevila J, Frye V, Richman BL (2000) The converging epidemics of mood-altering-drug use, HIV, HCV, and partner violence: a conundrum for methadone maintenance treatment. Mt Sinai J Med 67(0027–2507):452–464PubMed

Gilchrist G, Blazquez A, Torrens M (2011) Psychiatric, behavioural and social risk factors for HIV infection among female drug users. AIDS Behav 15(8):1834–1843. https://doi.org/10.1007/s10461-011-9991-1 CrossRefPubMed

Gilchrist G, Blázquez A, Torrens M (2012) Exploring the relationship between intimate partner violence, childhood abuse and psychiatric disorders among female drug users in Barcelona. Adv Dual Diagn 5(2):46–58. https://doi.org/10.1108/17570971211241895 CrossRef

Gilchrist G, Gruer L, Atkinson J (2007) Predictors of neurotic symptom severity among female drug users in Glasgow, Scotland. Drugs: Education, Prevention Policy 14:347–365

Gilchrist G, Swan D, Widyaratna K, Marquez-Arrico JE, Hughes E, Mdege ND, Martyn-St James M, Tirado-Munoz J (2017) A systematic review and meta-analysis of psychosocial interventions to reduce drug and sexual blood borne virus risk behaviours among people who inject drugs. AIDS Behav 21(7):1791–1811. https://doi.org/10.1007/s10461-017-1755-0 CrossRefPubMedPubMedCentral

Gilchrist G, Tirado-Muñoz J, Taylor A et al (2016) An uncontrolled, feasibility study of a group intervention to reduce hepatitis C transmission risk behaviours and increase transmission knowledge among women who inject drugs. Drugs Educ Prev Pol 24(2):179–188. https://doi.org/10.1080/09687637.2016.1197885

Hall W, Degenhardt L, Teesson M (2009) Reprint of “Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base”. Addict Behav 34(10):795–799. https://doi.org/10.1016/j.addbeh.2009.03.040 CrossRefPubMed

Hegarty K, Fracgp BR, Sheehan M (2005) The composite abuse scale: further development and assessment of reliability and validity of a multidimensional partner abuse measure in clinical settings. Violence Vict 20(5):529–547. https://doi.org/10.1891/0886-6708.2005.20.5.529 CrossRefPubMed

Hegarty K, Gunn J, Chondros P, Small R (2004) Association between depression and abuse by partners of women attending general practice: descriptive, cross sectional survey. BMJ 328(7440):621–624. https://doi.org/10.1136/bmj.328.7440.621 CrossRefPubMedPubMedCentral

Hegarty K, Sheehan M, Schonfeld C (1999) A multidimensional definition of partner abuse: development and preliminary validation of the composite abuse scale. J Fam Violence 14(4):399–415. https://doi.org/10.1023/A:1022834215681 CrossRef

Hutton HE, Lyketsos CG, Zenilman JM, Thompson RE, Erbelding EJ (2004) Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychol 161(5):912–914. https://doi.org/10.1176/appi.ajp.161.5.912 CrossRef

Iversen J, Page K, Madden A, Maher L (2015) HIV, HCV, and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquir Immune Defic Syndr 69(Suppl 1):S176–S181. https://doi.org/10.1097/QAI.0000000000000659 CrossRefPubMedPubMedCentral

Johnson SD, Cottler LB, O’Leary CC, Ben Abdallah A (2010) The association of trauma and PTSD with the substance use profiles of alcohol- and cocaine-dependent out-of-treatment women. Am J Addict 19(6):490–495. https://doi.org/10.1111/j.1521-0391.2010.00075.x CrossRefPubMedPubMedCentral

Kelly TM, Daley DC (2013) Integrated treatment of substance use and psychiatric disorders. Social Work Public Health 28(3–4):388–406. https://doi.org/10.1080/19371918.2013.774673 CrossRef

Kilpatrick DG, Acierno R, Resnick HS, Saunders BE, Best CL (1997) A 2-year longitudinal analysis of the relationships between violent assault and substance use in women. J Consult ClinPsychol 65(5):834–847. https://doi.org/10.1037/0022-006X.65.5.834 CrossRef

Li Y, Marshall CM, Rees HC, Nunez A, Ezeanolue EE, Ehiri JE (2014) Intimate partner violence and HIV infection among women: a systematic review and meta-analysis. J Int AIDS Soc 17:18845CrossRefPubMedPubMedCentral

Lövestad S, Löve J, Vaez M, Krantz G (2017) Prevalence of intimate partner violence and its association with symptoms of depression; a cross sectional study based on a female population sample in Sweden. BMC Public Health 17(1):335. https://doi.org/10.1186/s12889-017-4222-y CrossRefPubMedPubMedCentral

Magnus M, Kuo I, Phillips G, Rawls A, Peterson J, Montanez L, West-Ojo T, Jia Y, Opoku J, Kamanu-Elias N, Hamilton F, Wood A, Greenberg AE (2013) Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia. J Urban Heal 90(1):157–166. https://doi.org/10.1007/s11524-012-9687-5 CrossRef

Mandell W, Kim J, Latkin C, Suh T (1999) Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. Am J Drug Alcohol Abuse 25(1):117–127. https://doi.org/10.1081/ADA-100101849 CrossRefPubMed

Mason R, O'Rinn SE (2014) Co-occurring intimate partner violence, mental health, and substance use problems: a scoping review. Glob Health Action 7(1):24815. https://doi.org/10.3402/gha.v7.24815 CrossRefPubMed

McPherson MD, Delva J, Cranford JA (2007) A longitudinal investigation of intimate partner violence among mothers with mental illness. PsychiatrServ 58(5):675–680

Mestre-Pintó JI, Domingo-Salvany A, Martín-Santos R, Torrens M (2014) Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument. Eur Addict Res 20(1):41–48. https://doi.org/10.1159/000351519 CrossRefPubMed

Pallitto CC, García-Moreno C, Jansen HA, Heise L, Ellsberg M, Watts C, WHO Multi-Country Study on Women’s Health and Domestic Violence (2013) Intimate partner violence, abortion, and unintended pregnancy: results from the WHO multi-country study on women’s health and domestic violence. Int J Gynecol Obstet 120(1):3–9. https://doi.org/10.1016/j.ijgo.2012.07.003 CrossRef

Perdue T, Hagan H, Thiede H, Valleroy L (2003) Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Educ Prev 15(1):81–92. https://doi.org/10.1521/aeap.15.1.81.23842 CrossRefPubMed

Pettes T, Kerr T, Voon P, Nguyen P, Wood E, Hayashi K (2015) Depression and sexual risk behaviours among people who inject drugs: a gender-based analysis. Sex Health 12(3):224–230. https://doi.org/10.1071/SH14200 PubMedPubMedCentral

Pico-Alfonso MA, Garcia-Linares MI, Celda-Navarro N, Blasco-Ros C, Echeburúa E, Martinez M (2006) The impact of physical, psychological, and sexual intimate male partner violence on women’s mental health: depressive symptoms, posttraumatic stress disorder, state anxiety, and suicide. J Women's Health (Larchmt) 15(5):599–611. https://doi.org/10.1089/jwh.2006.15.599 CrossRef

Pilowsky DJ, LT W, Burchett B, Blazer DG, Ling W (2011) Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network. Subst Use Misuse 46(14):1716–1725. https://doi.org/10.3109/10826084.2011.611960 CrossRefPubMedPubMedCentral

REDUCE team (2013) Reducing hepatitis C sexual and drug taking risk behaviours among female drug users in Europe (REDUCE): translating evidence into practice. Available: https://thereduceproject.imim.es/

Rees S, Silove D, Chey T, Ivancic L, Steel Z, Creamer M, Teesson M, Bryant R, McFarlane AC, Mills KL, Slade T, Carragher N, O'Donnell M, Forbes D (2011) Lifetime prevalence of gender-based violence in women and the relationship with mental disorders and psychosocial function. JAMA 306(5):513–521. https://doi.org/10.1001/jama.2011.1098 CrossRefPubMed

Rhodes T, Davis M, Judd A (2004) Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction 99(5):621–633. https://doi.org/10.1111/j.1360-0443.2004.00692.x CrossRefPubMed

Roberts A, Mathers B, Degenhardt L (2010) Women who inject drugs: a review of their risks, experiences and needs 132 p. Available from: https://www.unodc.org/documents/hiv-aids/Women_who_inject_drugs.pdf

Scott N, Carrotte ER, Higgs P, Cogger S, Stoové MA, Aitken CK, Dietze PM (2016) Longitudinal changes in psychological distress in a cohort of people who inject drugs in Melbourne, Australia. Drug Alcohol Depend 1(168):140–146. https://doi.org/10.1016/j.drugalcdep.2016.08.638 CrossRef

Sobrino-Vegas P, Monge-Corella S, Serrano-Villar S, Gutiérrez F, Blanco JR, Santos I, del Romero J, Segura F, Portilla J, Guillén SM, del Amo J, CoRIS (2014) Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions. PLoS One 9(12):e116226. https://doi.org/10.1371/journal.pone.0116226 CrossRefPubMedPubMedCentral

Stein MD, Maksad J, Clarke J (2001) Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend 61(3):211–215. https://doi.org/10.1016/S0376-8716(00)00144-7 CrossRefPubMed

Stein MD, Solomon DA, Herman DS, Anderson BJ, Miller I (2003) Depression severity and drug injection HIV risk behaviors. Am J Psychiatry 160(9):1659–1662. https://doi.org/10.1176/appi.ajp.160.9.1659 CrossRefPubMed

Sutton R, Treloar C (2007) Chronic illness experiences, clinical markers and living with hepatitis C. J Health Psychol 12(2):330–340. https://doi.org/10.1177/1359105307074278 CrossRefPubMed

Tirado-Muñoz J, Gilchrist G, Lligoña E, Gilbert L, Torrens M (2015) A group intervention to reduce intimate partner violence among female drug users. Results from a randomized controlled pilot trial in a community substance-abuse center. Adicciones 27(3):168–178. https://doi.org/10.20882/adicciones.703 CrossRefPubMed

Topp L, Hudson SL, Maher L (2010) Mental health symptoms among street-based psychostimulant injectors in Sydney’s Kings Cross. Subst Use Misuse 45(7–8):1180–1200. https://doi.org/10.3109/10826080903443586 CrossRefPubMed

Torrens M, Gilchrist G, Domingo-Salvany A (2011) Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. Drug Alcohol Depend 113(2–3):147–156. https://doi.org/10.1016/j.drugalcdep.2010.07.013 CrossRefPubMed

Torrens M, Mestre-Pintó JI, Domingo-Salvany A (2015) Co-morbidity of substance use disorders and mental disorders in Europe. Europeang monitoring Centre for Drugs and Drug Addiction, Luxemburg

Torrens M, Rossi PC, Martinez-Riera R, Martinez-Sanvisens D, Bulbena A (2012) Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system. Subst Use Misuse 47(8–9):1005–1014. https://doi.org/10.3109/10826084.2012.663296 CrossRefPubMed

Trevillion K, Oram S, Feder G, Howard LM (2012) Experiences of domestic violence and mental disorders: a systematic review and meta-analysis. PLoS One 7(12):e51740. https://doi.org/10.1371/journal.pone.0051740 CrossRefPubMedPubMedCentral

Tuchman E (2010) Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis 29(2):127–138. https://doi.org/10.1080/10550881003684582 CrossRefPubMed

University of the West of Scotland, Health Protection Scotland, Glasgow Caledonian University and the West of Scotland Specialist Virology Centre. The Needle Exchange Surveillance Initiative (NESI): prevalence of HCV and injecting risk behaviours among people who inject drugs (PWID) attending injecting equipment provision services (IEPs) in Scotland, 2008/2009–2013/2014 University of the West of Scotland, January 2015

von Diemen L, De Boni R, Kessler F, Benzano D, Pechansky F (2010) Risk behaviors for HCV- and HIV-seroprevalence among female crack users in Porto Alegre, Brazil. Arch Womens Ment Health 13(3):185–191. https://doi.org/10.1007/s00737-009-0089-y CrossRef

Wagner KD, Hudson SM, Latka MH, Strathdee SA, Thiede H, Mackesy-Amiti ME, Garfein RS (2009) The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav 13(2):217–224. https://doi.org/10.1007/s10461-007-9309-5 CrossRefPubMed

Weaver T, Rutter D, Madden P, Ward J, Stimson G, Renton A (2001) Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Soc Psychiatry Psychiatr Epidemiol 36(8):399–406. https://doi.org/10.1007/s001270170030 CrossRefPubMed

Yarlott L, Heald E, Forton D (2017) Hepatitis C virus infection, and neurological and psychiatric disorders—a review. J Adv Res 8(2):139–148. https://doi.org/10.1016/j.jare.2016.09.005 CrossRefPubMed

Title: Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional study
Authors: Judit Tirado-Muñoz
Gail Gilchrist
Gabriele Fischer
Avril Taylor
Jacek Moskalewicz
Cinzia Giammarchi
Birgit Köchl
Alison Munro
Katarzyna Dąbrowska
April Shaw
Lucia Di Furia
Isabella Leeb
Caroline Hopf
Marta Torrens
Publication date: 01-06-2018
Publisher: Springer Vienna
Published in: Archives of Women's Mental Health / Issue 3/2018
Print ISSN: 1434-1816
Electronic ISSN: 1435-1102
DOI: https://doi.org/10.1007/s00737-017-0800-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional study

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Maternal depression trajectories from pregnancy to 3 years postpartum are associated with children’s behavior and executive functions at 3 and 6 years

Postpartum outcomes of a pilot prenatal care-based psychosocial intervention for PTSD during pregnancy

Efficacy of an Internet-based depression intervention to improve rates of treatment in adolescent mothers

Physical health, breastfeeding problems and maternal mood in the early postpartum: a prospective cohort study

Assessment of significant psychological distress at the end of pregnancy and associated factors

Risk factors for unplanned pregnancy in women with mental illness living in a developing country